NOVAST LABS FDA Approval ANDA 202015

ANDA 202015

NOVAST LABS

FDA Drug Application

Application #202015

Application Sponsors

ANDA 202015NOVAST LABS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL-283MG;0.03MG0YAELADROSPIRENONE; ETHINYL ESTRADIOL

FDA Submissions

ORIG1AP2014-11-19

Submissions Property Types

ORIG1Null19

TE Codes

001PrescriptionAB

CDER Filings

NOVAST LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202015
            [companyName] => NOVAST LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"YAELA","activeIngredients":"DROSPIRENONE; ETHINYL ESTRADIOL","strength":"3MG;0.03MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/19\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-11-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.